Taysha Gene Therapies Executives Sell Shares Amid Market Volatility.

Taysha Gene Therapies, Inc. (TSHA) has recently announced that its Chief Financial Officer, Alam Kamran, has sold a total of 23,849 shares at $4.61 per share on January 26, 2026, and an additional 78,968 shares at $4.75 per share on January 23, 2026. Furthermore, Director, President and Head of R&D Nagendran Sukumar has sold a total of 89,132 shares at $4.75 per share on January 23, 2026, and an additional 26,918 shares at $4.61 per share on January 26, 2026. Additionally, Director, Chief Executive Officer Nolan Sean P. has sold a total of 136,789 shares at $4.75 per share on January 23, 2026, and an additional 41,312 shares at $4.61 per share on January 26, 2026.